Lorlatinib trials for Lung cancer

All Lorlatinib trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Lorlatinib for Lung cancer

• A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib
  NCT06378892 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer
  NCT07617337 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context
  NCT06487078 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 31 locations
• Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer
  NCT07415005 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients
  NCT06361589 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of NXP900 With Lorlatinib in ALK+ Lung Cancer
  NCT07784959 · Phase: Phase 1 · Ages: No age limits stated · Sex: All (male and female) · 1 location

Common questions

How many trials study Lorlatinib for Lung cancer?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.